Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Shionogi & Ltd Un ADR (SGIOY)

Shionogi & Ltd Un ADR (SGIOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Shionogi & Ltd Un ADR 1-8 DOSHOMACHI 3-CHOME OSAKA M0 541-0045 JPN

www.shionogi.com P: 816-620-2216

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Shionogi & Co., Ltd. engages in the research, development, manufacture and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. Shionogi & Co., Ltd. is based in Osaka, Japan.

Key Statistics

Overview:

Market Capitalization, $K 14,921,095
Enterprise Value, $K 12,447,445
Shares Outstanding, K 1,701,379
Annual Sales, $ 2,893 M
Annual Net Income, $ 1,125 M
Last Quarter Sales, $ 767,610 K
Last Quarter Net Income, $ 299,610 K
EBIT, $ 234,850 K
EBITDA, $ 1,199 M
60-Month Beta 0.20
% of Institutional Shareholders 1.92%
Float, K 1,701,379
% Float 100.00%
Short Interest 124
Short Float 0.01%
Short Volume Ratio 0.26

Growth:

1-Year Return 27.66%
3-Year Return 5.32%
5-Year Return -1.76%
5-Year Revenue Growth -5.59%
5-Year Earnings Growth 8.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.18 on 10/27/25
Next Earnings Date 01/30/26
Earnings Per Share ttm 0.64
EPS Growth vs. Prev Qtr 12.50%
Annual Dividend & Yield 0.14 (1.60%)
Annual Dividend & Yield (Fwd) 0.13 (1.43%)
Most Recent Dividend 0.063 on 09/26/25
Next Ex-Dividends Date 09/26/25
Dividend Payout Ratio 11.82%
Most Recent Split 3-2 on 10/02/24

SGIOY Ratios

Ratio
Price/Earnings ttm 13.51
Price/Earnings forward 12.66
Price/Earnings to Growth 2.09
Return-on-Equity % 11.90%
Return-on-Assets % 10.63%
Profit Margin % 38.89%
Debt/Equity 0.00
Price/Sales 5.11
Price/Cash Flow 11.99
Price/Book 1.52
Book Value/Share 5.84
Interest Coverage 23.24

SGIOY Dividends

Date Value
09/26/25 $0.0630
09/28/24 $0.0560
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar